Orthofuse is developing a new generation of implants designed to improve the reversibility of procedures in challenging cases, simplify surgical procedures, and deliver better patient outcomes.
Orthopaedic trauma and spinal degenerative conditions often require procedures that are technically demanding, time-sensitive, and challenging when bone quality is poor. Current implant systems are often difficult to use consistently across varied clinical scenarios and cannot be repositioned without causing significant tissue damage. These limitations contribute to prolonged surgery times and increased risks for both patients and clinicians.
By leveraging advanced additive manufacturing techniques and novel implant architectures, Orthofuse is creating solutions designed to reduce the number of surgical steps while ensuring strong fixation.
According to James Scott, CEO and Co-Founder of Orthofuse: “Modern surgical practice demands implant systems that reflect the realities of the operating room. Orthofuse is developing a technology designed to simplify procedures, giving surgeons greater flexibility and confidence.”
